Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 1/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.43 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.40 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.40 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.40 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
| ▸ | METAP1 | P53582 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.37 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8744832 | 0.82 | MCL1 (0.42) | CYP11B1CYP11B2KDM4EADORA1ADORA2A | |
| SCHEMBL8744752 | 0.82 | ERBB2 (0.41) | ERBB2KDM4EADORA1ADORA2ANPSR1 | |
| SCHEMBL8744743 | 0.82 | MCL1 (0.41) | ERBB2KDM4EADORA1ADORA2ANPSR1 | |
| SCHEMBL7432291 | 0.81 | ADORA2A (0.41) | CYP11B1CYP11B2ERBB2KDM4EADORA1 | |
| SCHEMBL8744692 | 0.81 | CYP2A6 (0.43) | KDM4EHPGDMETAP2ALDH1A1CYP2A6 | |
| SCHEMBL8744753 | 0.81 | CTSS (0.49) | KDM4EADORA1ADORA2AHPGDLRRK2 | |
| SCHEMBL8744693 | 0.80 | CCNC (0.47) | ADORA1ADORA2AMAPTCYP1A2CYP3A4 | |
| SCHEMBL8744687 | 0.78 | KIF11 (0.47) | KDM5A | |
| SCHEMBL9876232 | 0.76 | MAPT (0.43) | ALDH1A1MAPTMEN1KMT2ANPC1 | |
| SCHEMBL8250696 | 0.75 | METAP2 (0.44) | KDM4EHPGDMETAP2METAP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115768517-B | Antimicrobial agent for non-human animals | 石原产业株式会社 | 2024-08-16 | — | — | CN | claimed |
| CN-115996714-A | Antifungal agent for human use | 石原产业株式会社 | 2023-04-21 | — | — | CN | claimed |
| CN-115768517-A | Antibacterial agent for non-human animals | 石原产业株式会社 | 2023-03-07 | — | — | CN | claimed |
| CN-107118160-B | A kind of preparation process of the chloro- 1H- imidazoles of 2- cyano -4- (p-methylphenyl) -5- | 盐城辉煌化工有限公司 | 2019-06-28 | — | — | CN | claimed |
| CN-115768517-B | Antimicrobial agent for non-human animals | 石原产业株式会社 | 2024-08-16 | — | — | CN | disclosed |
| US-20230255939-A1 | Antimicrobial Agent for Non-Human Animal | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| CN-115996714-A | Antifungal agent for human use | 石原产业株式会社 | 2023-04-21 | — | — | CN | disclosed |
| CN-115768517-A | Antibacterial agent for non-human animals | 石原产业株式会社 | 2023-03-07 | — | — | CN | disclosed |
| CN-110337434-B | Process for preparing 2-cyanoimidazole compounds | 安道麦马克西姆有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-107118160-B | A kind of preparation process of the chloro- 1H- imidazoles of 2- cyano -4- (p-methylphenyl) -5- | 盐城辉煌化工有限公司 | 2019-06-28 | — | — | CN | disclosed |
| CN-107118160-B | A kind of preparation process of the chloro- 1H- imidazoles of 2- cyano -4- (p-methylphenyl) -5- | 盐城辉煌化工有限公司 | 2019-06-28 | — | — | CN | disclosed |
| CN-108760920-A | A method of cyazofamid and its metabolite residue amount are measured based on HPLC-MSMS methods | 山东省农药科学研究院 | 2018-11-06 | — | — | CN | disclosed |
| EP-0653421-B1 | Process for preparing 2-cyanoimidazole compounds | ISHIHARA SANGYO KAISHA (JP) | 1997-01-15 | — | — | EP | disclosed |
| US-5552557-A | Process for preparing 2-cyanoimidazole compounds by reaction of an amino ketone compound | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1996-09-03 | — | — | US | disclosed |
| EP-0653421-A1 | Process for preparing 2-cyanoimidazole compounds | ISHIHARA SANGYO KAISHA LTD. (JP) | 1995-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255939-A1 | Antimicrobial Agent for Non-Human Animal | Q6ZSR9, SPTAN1, MPO | CYP11B1 4051/4885CYP11B2 3713/4885ERBB2 4598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.